Purchase Order 75N93021P00540

Award Date 4/14/21
Potential Completion Date 4/23/21
Potential Value $751K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $350,552.50 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a BD FACSymphony A3 Special Order System. The solicitation sought a BD FACSymphony A3 Cell Analyzer and associated equipment to support the Laboratory of Immunoregulation's research on HIV/AIDS and COVID-19. No set aside was designated for this sole source requirement to...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $719,435 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the delivery of one BD FACSymphony S6 Cell Sorter system. The system will meet requirements specified in the solicitation including the ability to simultaneously detect 50 parameters and sort clustered cell populations. It will be...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $260,967.29 firm fixed price purchase order to Becton, Dickinson and Company (BD) on June 15, 2020. The contract is for the BD FACSARIA FUSION SO LASER OPTION UPGRADE IN SUPPORT OF COVID-19. The contract is not set aside. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $550,885.74 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the purchase of one BD FACSymphony A5 SE Cell Analyzer system. The system will include the components listed in the attached bill of materials to the original solicitation and must meet technical requirements to detect up to 60...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $776,765.60 firm fixed price purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the purchase of one BD Biosciences FACSDISCOVER 8S Cell Sorter instrument. Performance will take place in San Jose, California over a period of approximately two months from September 2023 through November 2023. BD Biosciences...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $381k firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the provision of nine flow cytometers, three high throughput samplers, three flow supply systems, and twenty-four lasers. The place of performance for this one-year contract is San Jose, California and the period of performance runs from May...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $689,942.23 firm-fixed-price purchase order to Becton, Dickinson and Company's IDS division, doing business as BD Diagnostic System, for a BD FACSymphony System. The contract was awarded on September 18, 2018, with a completion date of September 28, 2018. This appears to be a stand-alone purchase order, as no set-aside was used. Becton, Dickinson is a global...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson & Co. (BD) for the purchase of a BD FACSymphony S6 cell sorter valued at $764,203.60. The contract has an ultimate completion date of September 29, 2025. The contract does not have a set-aside designation. BD has received numerous federal contract awards as both a prime and subcontractor...
The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $335,730.01 firm fixed price purchase order to Becton, Dickinson and Company for one BD FACSymphony A3 Flow Cytometer and FACSFlow Supply System. The place of performance will be Becton, Dickinson and Company's Franklin Lakes, New Jersey facility and the period of performance is from September 20, 2022 through February 24,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to Becton, Dickinson and Company (BD) for the supply of one FACSymphony A5 SORP & Fortessa System cell analyzer, valued at $574,988.05. The contract has no set-aside designation. BD is a global medical technology company that provides a wide range of equipment, reagents, and services to support biomedical research...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $751,407 purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for FACSymphony S6 analysis systems. The contract is associated with NIH's efforts to support coronavirus COVID-19 research and will provide the analysis systems to support this work. Performance will occur in San Jose, California over a period of approximately two weeks in mid-April 2021. The contract has a firm fixed price and no set-aside designation. No major subcontractors were identified. This purchase augments NIH's research infrastructure as it continues responding to the COVID-19 pandemic.

Generated 12/24/23, 11:36 PM